| The tumor immune contexture of prostate cancer N Vitkin, S Nersesian, DR Siemens, M Koti Frontiers in immunology 10, 603, 2019 | 182 | 2019 |
| NK cell infiltration is associated with improved overall survival in solid cancers: A systematic review and meta-analysis S Nersesian, SL Schwartz, SR Grantham, LK MacLean, SN Lee, ... Translational oncology 14 (1), 100930, 2021 | 113 | 2021 |
| Body image in older breast cancer survivors: A systematic review C Davis, P Tami, D Ramsay, L Melanson, L MacLean, S Nersesian, ... Psycho‐oncology 29 (5), 823-832, 2020 | 73 | 2020 |
| DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes T Vidotto, S Nersesian, C Graham, DR Siemens, M Koti Journal for immunotherapy of cancer 7, 1-12, 2019 | 73 | 2019 |
| Naturally killing the silent killer: NK cell-based immunotherapy for ovarian cancer S Nersesian, H Glazebrook, J Toulany, SR Grantham, JE Boudreau Frontiers in immunology 10, 469372, 2019 | 64 | 2019 |
| Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models D Newsted, S Banerjee, K Watt, S Nersesian, P Truesdell, LL Blazer, ... Oncoimmunology 8 (2), e1539613, 2019 | 47 | 2019 |
| Re-expression of miR-200c suppresses proliferation, colony formation and in vivo tumor growth of murine claudin-low mammary tumor cells R Jones, K Watson, A Bruce, S Nersesian, J Kitz, R Moorehead Oncotarget 8 (14), 23727, 2017 | 25 | 2017 |
| Multi‐omics in high‐grade serous ovarian cancer: Biomarkers from genome to the immunome C Clifford, N Vitkin, S Nersesian, G Reid‐Schachter, JA Francis, M Koti American Journal of Reproductive Immunology 80 (2), e12975, 2018 | 23 | 2018 |
| Effects of modulating actin dynamics on HER2 cancer cell motility and metastasis S Nersesian, R Williams, D Newsted, K Shah, S Young, PA Evans, ... Scientific Reports 8 (1), 17243, 2018 | 22 | 2018 |
| Mitochondrial damage-associated molecular patterns trigger arginase-dependent lymphocyte immunoregulation LP Westhaver, S Nersesian, A Nelson, LK MacLean, EB Carter, D Rowter, ... Cell Reports 39 (8), 2022 | 11 | 2022 |
| Illustrating your research: design basics for junior clinicians and scientists S Nersesian, N Vitkin, S Grantham, S Bourgaize bmj 370, 2020 | 9 | 2020 |
| Investigating the STING pathway to explain mechanisms of BCG failures in non-muscle invasive bladder cancer: prognostic and therapeutic implications M Koti, S Chenard, S Nersesian, T Vidotto, A Morales, DR Siemens Bladder Cancer 5 (3), 225-234, 2019 | 8 | 2019 |
| The STING pathway: therapeutic vulnerabilities in ovarian cancer N Shakfa, D Li, S Nersesian, J Wilson-Sanchez, M Koti British Journal of Cancer 127 (4), 603-611, 2022 | 7 | 2022 |
| Natural killer cells: The missing link in effective treatment for high-grade serous ovarian carcinoma M Pugh-Toole, AP Nicolela, S Nersesian, BM Leung, JE Boudreau Current Treatment Options in Oncology 23 (2), 210-226, 2022 | 7 | 2022 |
| What have we learned about the patient's experience of von Willebrand disease? A focus on women H VanderMeulen, S Arya, S Nersesian, N Philbert, M Sholzberg Hematology 2022 (1), 631-636, 2022 | 5 | 2022 |
| The Tumor Immune Contexture of Prostate Cancer. Front Immunol 2019; 10: 603 N Vitkin, S Nersesian, DR Siemens, M Koti | 5 | 2019 |
| Killer instincts: natural killer cells as multifactorial cancer immunotherapy S Nersesian, EB Carter, SN Lee, LP Westhaver, JE Boudreau Frontiers in Immunology 14, 1269614, 2023 | 1 | 2023 |
| Equity, Diversity and Inclusion in Canadian immunology: communication and complexity S Mashhouri, S Nantel, S Sultana, D Gatti, LP Westhaver, M Messing, ... Immunology and Cell Biology 101 (6), 473-478, 2023 | 1 | 2023 |
| The Importance of Iron Supplementation in Pregnant Women A Chanzu, M Wells, N Vitkin, S Nersesian Healthy Populations Journal 3 (2), 2023 | 1 | 2023 |
| Preparation of mitochondrial damage-associated molecular patterns from mouse liver tissue LP Westhaver, S Nersesian, A Nelson, LK MacLean, EB Carter, ... STAR protocols 3 (4), 101738, 2022 | 1 | 2022 |
